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The role of the neuropeptide oxytocin in social behaviors is one of the earliest discoveries in social
neuroscience. Influential studies in animal models have delineated many of the neural circuits and
genetic components that underlie these behaviors (Insel and Young, 2001; Donaldson and Young,
2008). These discoveries have inspired researchers to investigate the effects of oxytocin on brain
and behavior in humans (Kirsch et al., 2005; Kosfeld et al., 2005) and its potential as a treatment for
psychiatric disorders (Hollander et al., 2007; Andari et al., 2010; Guastella et al., 2010).
Several criticisms have been raised lately on the effects of intranasal oxytocin (IN-OT) in
humans such as weak effect sizes, lack of dose studies and ambiguity about chronic administration.
We clearly need more empirical data before drawing conclusions on IN-OT. Yet, how do we
approach these needs and how are we making progress with IN-OT or other oxytocin-targeted
drugs? Increasing the sample size and performing replications are important factors (Walum
et al., 2015), but are only part of the answer. We cannot minimize the importance of innovative
medium-sized studies that are based on theoretical frameworks or constructive hypotheses (or
even chance observations) that form the foundation of seminal discoveries. Even single-case studies
have advanced the field of neuroscience dramatically. Combining large data sets without a theory-
based approach and meticulous view of behavior and symptoms can lead to a dilution of important
findings and to misleading conclusions. Recent meta-analyses of the effects of IN-OT across all
psychiatric disorders and healthy subjects show that the overall effect sizes are low (Bakermans-
Kranenburg and Van, 2013; Walum et al., 2015), which some have interpreted to mean that all
the effects of IN-OT in humans are likely to be false positives and not true effects (Walum et al.,
2015). However, the effects on specific disorders (such as Autism Spectrum or ASD) are medium
to high, which indicates that IN-OT can be more beneficial for ASD than for psychiatric disorders
in general (Bakermans-Kranenburg and Van, 2013; Young and Barrett, 2015). Oxytocin’s role in
ASD is further supported by a seminal study showing that chronic IN-OT early in life restored
later social behavior in a mouse model of autism (Penagarikano et al., 2015). Other disorders, such
as PTSD (Post Traumatic Stress Disorder), might need further investigation. It has been recently
observed that IN-OT facilitates extinction of conditioned fear in healthy subjects (Eckstein et al.,
2015). Also, IN-OT is more beneficial for some individuals than others within healthy and ASD
populations (Andari et al., 2010; Bartz et al., 2010; Marsh et al., 2012; Riem et al., 2014) and some
studies include hypotheses and outcome measures that represent oxytocin’s effects and its function
better than others.
More research on how individual social aptitudes and emotional regulation, clinical
characteristics, receptor distribution and genetic polymorphisms can affect the social outcome of
oxytocin-based treatments is needed. It is crucial to know more precisely who can benefit from
oxytocin-related treatments, which outcome measures will best represent its effects, how it should
be administered, and what are the brain mechanisms. This “precision medicine” approach for IN-
OT is in line with the Research Domain Criteria of the U.S. National Institute of Mental Health
(Cuthbert and Insel, 2013).
Andari “Precision Medicine” approach for Oxytocin
This special issue collects 12 interesting papers on the many
facets of the oxytocin system and social behavior. This topic
embraces a very interesting aspect of oxytocin biology, which
is the evolution of its function (Knobloch and Grinevich,
2014, this issue). Oxytocin-like genes and peptides are highly
conserved and homologs are even observed in primitive
invertebrate species such as insects and mollusks. However, the
oxytocin system went through tremendous microanatomical and
cytological transformations during evolution. Along with the
development of the forebrain, the ancestral preoptic nucleus
in basal vertebrates (fish) diverged into a polycentric oxytocin
system (paraventricular and supraoptic nuclei) in advanced
vertebrates (reptiles, birds and mammals). Oxytocin neurons
acquired a voluminous dendritic trees and branching axons
along with an expansion of oxytocin axonal projections to
forebrain regions, a physiological advancement that shapes the
complexity of evolved social behaviors. This topic also includes
a novel finding on the distinct regional developmental changes
in oxytocin receptor density (OXTR) over postnatal time in a
mouse model (Hammock and Levitt, 2013, this issue). OXTR
density or distribution or gene polymorphisms can shape social
behavior and can be a moderator of the degree of susceptibility
to early adverse experiences (Anacker and Beery, 2013, this
issue; Parker et al., 2014; Barrett et al., 2015). In this issue are
two genetic imaging papers that showed correlations between
polymorphisms of the OXTR gene and social outcome and the
BOLD activity of social brain regions in humans (Verbeke et al.,
2013, this issue; Michalska et al., 2014, this issue). Not only does
oxytocin system shape social outcomes, environmental factors
like early-life stress can also impact the oxytocin system such as
its endogenous release (Crockford et al., 2014, this issue).
Also included in this topic are two papers on rhesusmacaques,
which are a valuable model for examining the neurobiology
of socioemotional behaviors due to the physiological and
social complexity that they share with humans. Authors found
that peripheral measures of oxytocin and vasopressin in
juveniles rhesus monkeys are influenced by early involvement
in friendship (Weinstein et al., 2014, this issue). In another
interesting study, IN-OT enhanced socially-reinforced learning
in rhesus monkeys which were trained on an implicit visual
matching task (Parr, 2014, this issue). These results are, in part,
congruent with the model proposed in this special issue stating
that IN-OT is likely to increase reward sensitivity and reduce
anxiety in order to enhance social salience and social cognition
(Bethlehem et al., 2014, this issue).
There is a current debate in the literature on whether
oxytocin is promoting positive prosocial behaviors or whether it
is triggering negative behaviors such as defensive mechanisms.
In this special issue, authors found that IN-OT increased the
bias for “liking” in-group stimuli and did not increase out-group
derogation in humans (Ma et al., 2014, this issue). IN-OT is
not necessarily the peace or the war molecule; its role in social
functioning is likely to be more complex. Its action is likely to be
adaptive in impacting a variety of socio-emotional behaviors based
on contextual demands and individual predispositions, possibly
through its interaction with GABAergic neurons (Tyzio et al.,
2014), serotonin (Mottolese et al., 2014), reward system (Burkett
and Young, 2012) and neuronal signaling (Owen et al., 2013;
Marlin et al., 2015). Pro-social behaviors but also dominance,
defensive behaviors and other behaviors are necessary for our
social structure and adaptation. In a very interesting review
(Ebitz and Platt, 2013, this issue), authors stressed how for
a greater evolutionary fitness, oxytocin’s function is adaptive
and is species-specific. Notably, in another review, authors
discussed the variability and the different types of social behavior
(aggression, engagement, grooming, dominance) between species
(Anacker and Beery, 2013, this issue), a fact that should be taken
into account when drawing conclusions on the effects of oxytocin
on behavior.
Despite the progress in this field, there are important
questions that still need to be addressed. Who can benefit from
oxytocin intake? How do we measure the predicted value of
oxytocin-based benefits? Does IN-OT penetrate the brain? IN-
OT increases oxytocin levels in the brain (Neumann et al., 2013;
Striepens et al., 2013) and increases brain activity and resting
cerebral blood flow (Domes et al., 2013; Gordon et al., 2013;
Paloyelis et al., 2014). More research dissociating exogenous
from endogenous effects of oxytocin can lead the field forward.
Importantly, in this special issue, authors raised precautions
about the risks and the effects of chronic IN-OT in pediatric
populations (Taylor et al., 2014, this issue). A few chronic
IN-OT studies have shown that it is safe in young (7–18
years old) and adult populations but with ambiguous social
outcomes (Anagnostou et al., 2012; Tachibana et al., 2013;
Dadds et al., 2014; Guastella et al., 2015). Recently, it has been
shown that stimulating the oxytocin system endogenously with
melanocortin-4 receptor agonist (Barrett et al., 2014; Modi et al.,
2015) or MDMA (Dumont et al., 2009) is promising but also
needsmore investigation.More research on the primary outcome
measures, the methods of treatment (drugs, doses, chronic
administration with behavioral therapies), and the individual
variability in endogenous oxytocin release following new drug
treatments and their side effects, is needed.
Oxytocin is an exciting target for improving social function,
yet there is a gap between theory and actual therapeutic
applications. Studying interactions between neuropeptides, brain
mechanisms of social functions, inter-individual variability, and
combining neurobiology with behavioral therapies can lead
to better outcomes. With a powerful sense of determination
and optimism, respect of each other fields, multidisciplinary
collaborations, careful replications and adoption of a “precision
medicine” approach within fundamental science and human
research; we together can help men and women who suffer from
brain dysfunctions.
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